Prostate cancer after exogenous testosterone replacement therapy in a patient with pituitary insufficiency.
We present the case of a patient who was diagnosed with prostate cancer after 15 years of exogenous testosterone therapy. We discuss the literature on testosterone treatment, its possible prostatic complications and guidelines for monitoring the prostate during treatment.
Halland
Adrian
A
Department of Urology, Aalborg Hospital, 9100 Aalborg, Denmark.
Jønler
Morten
M
Pedersen
Knud V
KV
D000230:Adenocarcinoma / Q000139:chemically induced*; D000728:Androgens / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007018:Hypopituitarism / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000139:chemically induced*; D013739:Testosterone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D013997:Time Factors
D000728:Androgens; D013739:Testosterone; D017430:Prostate-Specific Antigen